Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.6B | 13.3B | 13.1B | 12.9B |
Cost of revenue | 10.6B | 10.2B | 10.2B | 9.8B |
Gross profit | 3.0B | 3.0B | 2.8B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 842M | 958M | 831M | 1.1B |
Operating income | 1.9B | 1.8B | 1.7B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 49M | 37M | 45M | 42M |
Other income expense | — | — | — | — |
Pretax income | 2.3B | 2.1B | 2.1B | 2.1B |
Tax provision | 534M | 505M | 522M | 518M |
Net income | 1.8B | 1.6B | 1.6B | 1.6B |
Basic EPS | — | 7.0 | 6.9 | 7.0 |
Diluted EPS | — | 7.0 | 6.8 | 6.9 |
Basic average shares | — | 227.0M | 226.3M | 226.9M |
Diluted average shares | — | 228.9M | 228.3M | 228.5M |
EBITDA | 2.6B | 2.4B | 2.4B | 2.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |